Αποτελέσματα Αναζήτησης
1 Μαΐ 2018 · Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + TH (Taxol® + Herceptin®) is a Chemotherapy Regimen for Breast Cancer - early stage. How does Dose-Dense AC + TH work? Doxorubicin, cyclophosphamide, and paclitaxel are designed to kill or slow the growth of cancer cells.
Adjuvant chemotherapy improves outcomes of operable breast cancer. Since the landmark study of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil (1), there has been an ongoing effort to identify better regimens to improve survival and decrease toxicity.
2 Σεπ 2021 · Abstract. Background. To analyze the cost-effectiveness of Doxorubicin/cyclophosphamide/Paclitaxel/trastuzumab (AC-TH) and Docetaxel/Carboplatin/trastuzumab (TCH). Methods. A Markov model was built to simulate the process of breast cancer events and death occurred in both AC-TH and TCH armed patients and to choose a suitable chemotherapy method.
28 Οκτ 2021 · Biological therapies have changed the face of oncology by targeting cancerous cells while reducing the effect on normal tissue. This publication focuses mainly on new therapies that have contributed to the advances in treatment of certain malignancies.
7 Δεκ 2022 · The following material represents a subset of chemotherapy and immunotherapy regimens that are used for the treatment of patients with breast cancer, both in the adjuvant and neoadjuvant settings.
31 Ιουλ 2017 · An analysis of the SEER-Medicare database shows that outcomes and healthcare costs for the two chemotherapy regimens are similar, with one difference.
31 Αυγ 2015 · AC-T (doxorubicin and cyclophosphamide followed by paclitaxel), also called AC-T and AC- Taxol, is a chemotherapy combination treatment used to treat breast cancer. It contains these medicines: Doxorubicin (Adriamycin) - a type of chemotherapy medicine called an anthracycline.
